ELEGANCE Machine learning for integrated multi-parametric enzyme and bioprocess design
- Coordinator
- Danmarks Tekniske Universitet, Denmark
- Runs
- 1 January 2026 to 31 December 2029
- Status
- Running
- EU funding
- €4.5m
- Total cost
- —
- Partners
- 28 organisations in 12 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101226960
What the project is doing
In the project's own words, from its summary on CORDIS.
Currently, our world is facing several global challenges like climate change, water pollution, land erosion, resource depletion and unsustainable manufacturing. Biotechnology can provide many solutions to these problems. One example is the development of sustainable bioprocesses, which is at the heart of the EU’s green deal. Enzymes are nature’s catalysts at the core of such transformation since they can catalyse complex biocatalytic reactions.
Biocatalysis has been slowly but gradually displacing traditional organic chemistry in several processes by virtue of its better efficacy, with the added value of being less wasteful as evidenced by the cornucopia of EPA Green Chemistry Awards conferred to enzymatic processes. Thanks to protein directed evolution (Nobel Prize 2018), enzyme function can be tailored to new-to-nature industrial conditions within bioreactors.
However, there are still many challenges limiting bioprocess scalability, owing to a lack of deep understanding of enzyme function and of efficient strategies to overcome the complex multi-factorial optimisation problem of both enzymes and bioprocesses. To address this gap, also known as the valley of death (i.e., a large investment gap between fundamental and applied research), ELEGANCE will offer a unique educational program combining state-of-the-art experimental and computational approaches including data science and artificial intelligence to design better enzymes and bioprocesses faster.
The main goal is to train a new generation of specialists with essential hard and soft skills for transforming biocatalysis into a data-driven discipline to accelerate bioprocess development, thereby anticipating potential challenges arising in the valley of death. ELEGANCE will focus on enzymes catalysing highly selective oxyfunctionalisation reactions, unattainable through existing chemical technology, with ecological and economic attractiveness to enable the transition to a circular bioeconomy in many industries.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Coordinator |
| Acib GmbH | Graz | Austria | Participant |
| Innophore GmbH | Graz | Austria | Associatedpartner |
| Technische Universitaet Graz | Graz | Austria | Associatedpartner |
| myBIOS GmbH | Graz | Austria | Associatedpartner |
| Universite De Montreal | Montreal | Canada | Associatedpartner |
| Ceske Vysoke Uceni Technicke V Praze | Praha | Czechia | Participant |
| Masarykova univerzita | Brno | Czechia | Participant |
| Exazyme GmbH | Berlin | Germany | Associatedpartner |
| Freie Universitaet Berlin | Berlin | Germany | Participant |
| University of Stuttgart | Stuttgart | Germany | Associatedpartner |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Novozymes A/s | Bagsvaerd | Denmark | Associatedpartner |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Evoenzyme SL | Madrid | Spain | Associatedpartner |
| Universidad Autonoma De Madrid | Madrid | Spain | Associatedpartner |
| Universitat De Girona | Girona | Spain | Participant |
| Nantes Universite | Nantes | France | Associatedpartner |
| Peaccel | La Bretagne - Sainte-Clotilde | France | Participant |
| Proteus | Longjumeau | France | Associatedpartner |
| Sveuciliste U Zagrebu Fakultet Kemijskog Inzenjerstva I Tehnologije | Zagreb | Croatia | Participant |
| Datahow S.r.l. | Milano | Italy | Participant |
| Universita Degli Studi Di Padova | Padova | Italy | Associatedpartner |
| Universita Degli Studi Di Torino | Torino | Italy | Participant |
| Technische Universiteit Delft | Delft | Netherlands | Participant |
| Astrazeneca AB | Sodertaelje | Sweden | Associatedpartner |
| Enginzyme AB | Stockholm | Sweden | Associatedpartner |
| University of Bristol | Bristol | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI